Rapid effect of mosapride citrate, 5-HT4 receptor agonist, on fasting blood glucose in Type 2 diabetes patients.
Ueno
Naohiko
N
Satoh
Yoshiko
Y
D000284:Administration, Oral; D000368:Aged; D001549:Benzamides / Q000008:administration & dosage / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood; D009025:Morpholines / Q000008:administration & dosage / Q000627:therapeutic use*; D058828:Serotonin 5-HT4 Receptor Agonists; D013997:Time Factors; D016896:Treatment Outcome
D001549:Benzamides; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D009025:Morpholines; D058828:Serotonin 5-HT4 Receptor Agonists; C062720:mosapride